Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kerstin Lanbeck Vallén"'
Autor:
Anna Breitholtz-Emanuelsson, Bo Fransson, Charlotte Edenius, Stig Strid, Kerstin Lanbeck Vallén, Olof Borgå
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 11:34-42
The tolerability, safety, and pharmacokinetics of NXY-059, a nitrone-based free radical trapping agent under development for the treatment of acute ischemic stroke, were investigated in 2 double-blind, placebo-controlled dose-escalation studies in he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::325a72c074a581e3699a2aba028df4bd
https://doi.org/10.1053/jscd.2002.123973
https://doi.org/10.1053/jscd.2002.123973
Autor:
A. Richard Green, Hallgrimur Jonasson, Éva Lindström Böö, Mark Campbell, Stefan Lundquist, Tim Ashwood, Kerstin Lanbeck-Vallén
Publikováno v:
Brain Research. 1072:224-226
The penetration of the free radical trapping neuroprotectant NXY-059 into the brain has been examined in rats subjected to permanent middle cerebral artery occlusion (pMCAO). NXY-059 (125 mg/kg bolus followed by 125 mg/kg/h) was infused for 4 h 45 mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33fba65667b0fcc7978c2a25fcfaaf80
https://doi.org/10.1016/j.brainres.2005.12.035
https://doi.org/10.1016/j.brainres.2005.12.035
Publikováno v:
Therapeutic drug monitoring. 2(4)
A 2 year history of severe diarrhea, tiredness, and weight loss in a female patient could not be diagnosed satisfactorily despite repeated and extensive clinical investigations of various kinds. The final diagnosis of laxative abuse was arrived at af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836f2146a8aa2db38f75fdba72fa87a3
https://pubmed.ncbi.nlm.nih.gov/7222187
https://pubmed.ncbi.nlm.nih.gov/7222187